Search
Close this search box.

Multi-omics of iCPET Plasma Samples

This project aims to understand the origin of postural orthostatic tachycardia syndrome (POTS).

  • Wenzhong Xiao, PhD
  • David Systrom, MD
  • Ron Tompkins, MD/ScD (passed away in 2022)
  • The multi-omics of the samples, including cytokines, metabolomics, and proteomics, was completed.
  • There is an enhanced pro-inflammatory cytokine response between the pulmonary and radial arteries in ME/CFS patients compared to symptomatic controls.
  • The small molecule metabolic response to exercise appears comparable or exaggerated between the ME/CFS patients and symptomatic controls, depending upon the computational approach.
  • Proteomic profiles of the radial and pulmonary arteries have been obtained.
  • We have identified the signature of three proteins that distinguish ME/CFS from controls.
  • Manuscripts on molecular signatures are in preparation.
STUDY HYPOTHESIS AND DESCRIPTION

POTS is one of the more common symptoms of ME/CFS. This syndrome appears to involve the cardiopulmonary and peripheral vascular systems, both are modulated by the autonomic nervous system. It is unclear why these systems become dysfunctional to cause POTS but understanding the biological pathology underlying it will be relevant to helping understand its relationship to ME/CFS.

Cardiopulmonary exercise testing together with direct measurement through invasive arterial catheters (iCPET) has been useful to define the reason for unexplained dyspnea in general populations thought to be heart or lung in origin. Using this same diagnostic tool, ME/CFS patients have been evaluated and found to demonstrate a preload failure (PLF) pattern under maximum exercise. There are two forms of this PLF that has been observed: low flow and high flow. The low flow phenotype appears to be consistent with a failure of the autonomic nervous system to shift blood from the venous to the arterial side of the circulation or another possibility is a reduced total blood volume. On the other hand, the high flow phenotype appears as an arterial to venous shunt in the peripheral circulation or another possibility is a reduced oxygen delivery to peripheral circulatory beds or a reduced utilization by the mitochondria. 

OBJECTIVES

  1. Systematically study the plasma and phospho-proteome and plasma metabolome in ME/CFS patients using the readily available plasma tissue repository at the Brigham Women’s Hospital to:
    • Determine differentially regulated proteins and peptides.
    • Determine differences in small molecule metabolites.
  1. Conduct proteomic and metabolomic analyses on ME/CFS patient blood samples obtained before, during, and one hour after an iCPET procedure for comparison to those from control volunteers also undergoing iCPET testing.


Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia Leading Research. Delivering Hope.Open Medicine Foundation®

What are the advantages of giving from your Donor Advised Fund (DAF)?

  • Your gifts to your donor advised fund entitle you to an immediate income tax deduction at the time of contribution.
  • You avoid capital gains tax on appreciated assets you place in your donor advised fund.
  • Your fund’s investment gains accumulate tax free.
  • Funds are distributed to Open Medicine Foundation in your name and immediately put to use to support our worldwide research efforts.


How do I make a donation through my DAF?

Just click on the DAF widget below. It is simple and convenient to find your fund among the over 900 funds in our system.

Still can’t find your fund? 

  • Request a grant distribution through your Donor Advised Fund sponsor
  • Be sure to use OMF’s EIN #26-4712664
  • You can also designate OMF as a beneficiary for your Donor Advised Fund
  • Questions? Give us a call at 650-242-8669